Other Species / Isoforms
  NOT3 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K41-ub
NAANANQkEKYEADL
0 1
NOT3 (human) NAANANQkEKYEADL K41-ub
NOT3 (mouse) NAANANQKEKYEADL K41
NOT3 (rat) NAANANQKEKYEADL K41
K82-ub
RQLIDNRkLIETQME
0 1
NOT3 (human) RQLIDNRkLIETQME K82-ub
NOT3 (mouse) RQLIENRKLIETQME K82
NOT3 (rat) RQLIENRKLIETQME K82
S104-p
ETKTKAYskEGLGLA
0 2
NOT3 (human) ETKTKAYskEGLGLA S104-p
NOT3 (mouse) ETKTKAYSKEGLGLA S104
NOT3 (rat) ETKTKAYSKEGLGLA S104
K105-ub
TKTKAYskEGLGLAQ
0 1
NOT3 (human) TKTKAYskEGLGLAQ K105-ub
NOT3 (mouse) TKTKAYSKEGLGLAQ K105
NOT3 (rat) TKTKAYSKEGLGLAQ K105
K170
QDRIEGLKRHIEKHR
0 1
NOT3 (human) QDRIEGLKRHIEKHR K170
NOT3 (mouse) QDRIEGLKRHIEKHR K170
NOT3 (rat) QDRIEGLkRHIEKHR K170-ac
S194-p
LRMLDNDsILVDAIR
0 2
NOT3 (human) LRMLDNDsILVDAIR S194-p
NOT3 (mouse) LRMLDNDsILVDAIR S194-p
NOT3 (rat) LRMLDNDSILVDAIR S194
S245-p
LVATSPPsHSHMEDE
0 1
NOT3 (human) LVATSPPsHSHMEDE S245-p
NOT3 (mouse) LVATSPPSHSHMEDE S245
NOT3 (rat) LVATSPPSHSHMEDE S245
S291-p
DDKKRGRstDsEVsQ
Upstream
0 11
Treatment
  • selumetinib
  • vemurafenib
NOT3 (human) DDKKRGRstDsEVsQ S291-p
NOT3 (mouse) DDKKRGRStDsEVSQ S291
NOT3 (rat) DDKKRGRSTDSEVSQ S291
T292-p
DKKRGRstDsEVsQs
0 14
NOT3 (human) DKKRGRstDsEVsQs T292-p
NOT3 (mouse) DKKRGRStDsEVSQs T292-p
NOT3 (rat) DKKRGRSTDSEVSQs T292
S294-p
KRGRstDsEVsQsPA
0 3
NOT3 (human) KRGRstDsEVsQsPA S294-p
NOT3 (mouse) KRGRStDsEVSQsPA S294-p
NOT3 (rat) KRGRSTDSEVSQsPA S294
S297-p
RstDsEVsQsPAKNG
0 5
NOT3 (human) RstDsEVsQsPAKNG S297-p
NOT3 (mouse) RStDsEVSQsPAKNG S297
NOT3 (rat) RSTDSEVSQsPAKNG S297
S299-p
tDsEVsQsPAKNGSK
Upstream
0 32
Treatment
  • hypoxia
  • rapamycin
NOT3 (human) tDsEVsQsPAKNGSK S299-p
NOT3 (mouse) tDsEVSQsPAKNGSK S299-p
NOT3 (rat) TDSEVSQsPAKNGSK S299-p
S436
YSSVVADSPAEVALS
0 1
NOT3 (human) YSSVVADSPAEVALS S436
NOT3 (mouse) YSSVVADsPAEVTLS S434-p
NOT3 (rat) YSSVVADSPAEVALS S434
S451
SSGGNNASSQALGPP
0 1
NOT3 (human) SSGGNNASSQALGPP S451
NOT3 (mouse) SSGGSSAssQALGPT S449-p
NOT3 (rat) SSGGSSASSQALGPT S449
S452
SGGNNASSQALGPPS
0 1
NOT3 (human) SGGNNASSQALGPPS S452
NOT3 (mouse) SGGSSAssQALGPTS S450-p
NOT3 (rat) SGGSSASSQALGPTS S450
S467-p
GPHNPPPstsKEPSA
0 1
NOT3 (human) GPHNPPPstsKEPSA S467-p
NOT3 (mouse) GPHNPAPSTSKESST S465
NOT3 (rat) GPHNPAPSTLKESST S465
T468-p
PHNPPPstsKEPSAA
0 1
NOT3 (human) PHNPPPstsKEPSAA T468-p
NOT3 (mouse) PHNPAPSTSKESSTA T466
NOT3 (rat) PHNPAPSTLKESSTA T466
S469-p
HNPPPstsKEPSAAA
0 1
NOT3 (human) HNPPPstsKEPSAAA S469-p
NOT3 (mouse) HNPAPSTSKESSTAA S467
NOT3 (rat) HNPAPSTLKESSTAA L467
S506-p
PLPVNPPsSPTPSFS
0 1
NOT3 (human) PLPVNPPsSPTPSFS S506-p
NOT3 (mouse) PLPVNPPSSPTPSFS S504
NOT3 (rat) PLPVNPPSSPTPSFS S504
A531
GPPQFSTAPEIKAPE
0 6
NOT3 (human) GPPQFSTAPEIKAPE A531
NOT3 (mouse) GPPQFSTtPEIKAPE T529-p
NOT3 (rat) GPPQFSTTPEIKAPE T529
S541-p
IKAPEPLssLKSMAE
0 2
NOT3 (human) IKAPEPLssLKSMAE S541-p
NOT3 (mouse) IKAPEPLSSLKSMAE S539
NOT3 (rat) IKAPEPLSSLKSMAE S539
S542-p
KAPEPLssLKSMAER
0 3
NOT3 (human) KAPEPLssLKSMAER S542-p
NOT3 (mouse) KAPEPLSSLKSMAER S540
NOT3 (rat) KAPEPLSSLKSMAER S540
R635-m1
PSDSERIrQYLPRNP
0 3
NOT3 (human) PSDSERIrQYLPRNP R635-m1
NOT3 (mouse) PSDSERIRQYLPRNP R633
NOT3 (rat) PSDSERIRQYLPRNP R633
T645-p
LPRNPCPtPPYHHQM
0 1
NOT3 (human) LPRNPCPtPPYHHQM T645-p
NOT3 (mouse) LPRNPCPTPPYHHQM T643
NOT3 (rat) LPRNPCPTPPYHHQM T643
Y685-p
LEGTKAQyLAAkALK
0 1
NOT3 (human) LEGTKAQyLAAkALK Y685-p
NOT3 (mouse) LEGTKAQYLAAKALK Y683
NOT3 (rat) LEGTKAQYLAAKALK Y683
K689-ub
KAQyLAAkALKKQSW
0 1
NOT3 (human) KAQyLAAkALKKQSW K689-ub
NOT3 (mouse) KAQYLAAKALKKQSW K687
NOT3 (rat) KAQYLAAKALKKQSW K687
K737-ub
EKWGQRKkEGFTFEY
0 1
NOT3 (human) EKWGQRKkEGFTFEY K737-ub
NOT3 (mouse) EKWGQRKKEGFTFEY K735
NOT3 (rat) EKWGQRKKEGFTFEY K735
Y746-p
GFTFEYRyLEDRDLQ
0 1
NOT3 (human) GFTFEYRyLEDRDLQ Y746-p
NOT3 (mouse) GFTFEYRYLEDRDLQ Y744
NOT3 (rat) GFTFEYRYLEDRDLQ Y744